Palmetto GBA Executive and Leadership Team

Nancy Lybrand, the Vice President & Chief Financial Officer at Palmetto GBA, directs all fiscal planning and budgetary oversight for the organization. Managing the financial health of high-volume claims processing operations, Lybrand ensures strict adherence to federal compliance standards. The Vice President & Chief Financial Officer collaborates with executive leadership to allocate resources toward technical service enhancements and contact center scalability. By monitoring revenue cycles and cost structures, Lybrand optimizes the financial performance of the company across diverse commercial and government contracts. This leadership role involves rigorous analysis of market trends to support long-term sustainability. Nancy Lybrand maintains fiscal integrity while driving growth initiatives that align with the broader mission of providing reliable transaction services. Through precise financial modeling and risk assessment, Lybrand secures the capital necessary for ongoing infrastructure investments, ultimately strengthening the market position of the firm within the competitive business services sector.

Mike Gurrera, the Vice President & Amp. Chief Financial Officer at Palmetto GBA, manages corporate accounting and internal audit functions to ensure operational transparency. Focusing on the financial logistics of large-scale government contracts, Gurrera implements strategies that improve transaction processing efficiency. The Vice President & Amp. Chief Financial Officer works closely with the board to evaluate investment opportunities in new technical service platforms. By streamlining procurement processes and managing capital expenditures, Gurrera supports the overall profitability of the organization. This role requires constant monitoring of economic indicators to mitigate financial risks associated with federal service delivery. Mike Gurrera maintains a disciplined approach to asset management, ensuring that all departments operate within established budgetary constraints. Through the development of robust financial reporting systems, Gurrera provides the executive team with actionable data, facilitating informed decision-making that enhances the long-term value of the company for all stakeholders.

Margaret Price, the Vice President & Chief Technology Officer at Palmetto GBA, architects the digital infrastructure required for high-volume claims processing and secure data management. Overseeing the development of advanced technical services, Price ensures that all platforms meet the rigorous security requirements of federal government clients. The Vice President & Chief Technology Officer leads cross-functional teams to integrate emerging technologies into existing contact center operations, thereby increasing throughput and accuracy. By prioritizing cybersecurity and system resilience, Price protects sensitive information while maintaining continuous service availability. This leadership role involves evaluating new software solutions to improve the efficiency of transaction processing workflows. Margaret Price drives innovation by aligning technical roadmaps with the evolving needs of commercial and federal partners. Through the implementation of scalable cloud solutions and automated processing tools, Price enhances the technological capabilities of the firm, ensuring that the organization remains at the forefront of the industry.

Nella Bishop, the Vice President and Chief Information Officer, Systems and Support at Palmetto GBA, manages the complex information systems that underpin all contact center and claims processing activities. Focusing on system reliability and user support, Bishop ensures that internal teams possess the tools necessary for seamless service delivery. The Vice President and Chief Information Officer, Systems and Support coordinates with technical departments to maintain high uptime for critical government applications. By optimizing data architecture and support protocols, Bishop improves the overall responsiveness of the organization to client inquiries. This role involves overseeing the lifecycle of information technology assets and ensuring that all systems comply with federal regulations. Nella Bishop drives operational efficiency by streamlining support workflows and implementing user-friendly interfaces for internal staff. Through the strategic management of information systems, Bishop supports the broader mission of providing high-quality, reliable services to federal and commercial customers across the country.

Mark Pilley, the Chief Medical Officer at Palmetto GBA, provides clinical leadership for the evaluation of medical claims and the development of health policy standards. Overseeing the medical review process, Pilley ensures that all claims processing activities align with current clinical guidelines and federal regulations. The Chief Medical Officer collaborates with internal teams to interpret complex medical data, facilitating accurate and timely decision-making for government programs. By establishing rigorous clinical criteria, Pilley maintains the integrity of the claims review process and supports the delivery of high-quality healthcare services. This leadership role involves engaging with medical professionals and regulatory bodies to refine policy frameworks. Mark Pilley drives clinical excellence by integrating evidence-based practices into the operational workflows of the company. Through the application of deep medical expertise, Pilley ensures that the organization effectively manages the clinical aspects of its high-volume transaction processing business, ultimately benefiting both the federal government and the patients served.

Gabriel Bien-Willner, the Medical Director & Chief Medical Officer, Moldx, Palmetto Gba at Palmetto GBA, leads the clinical assessment of molecular diagnostic tests within the MolDX program. Focusing on the intersection of genomics and medical policy, Bien-Willner evaluates the clinical utility and validity of new diagnostic technologies. The Medical Director & Chief Medical Officer, Moldx, Palmetto Gba works with laboratory partners to ensure that diagnostic services meet the necessary standards for federal reimbursement. By developing evidence-based coverage policies, Bien-Willner influences the adoption of innovative medical technologies across the healthcare landscape. This role involves analyzing complex clinical data to support policy decisions that impact patient access to advanced diagnostics. Gabriel Bien-Willner drives the strategic direction of the MolDX program, ensuring that the organization remains a leader in molecular diagnostic oversight. Through rigorous clinical evaluation and collaboration with industry stakeholders, Bien-Willner maintains the high standards required for federal health programs.

Angella Charnot- Katsikas, the Medical Director & Chief Medical Officer, Moldx at Palmetto GBA, oversees the clinical review of molecular diagnostic tests to ensure compliance with federal coverage policies. Focusing on the scientific validation of diagnostic assays, Charnot- Katsikas provides expert guidance on the clinical necessity of emerging medical technologies. The Medical Director & Chief Medical Officer, Moldx collaborates with laboratory directors and clinical experts to refine the criteria for diagnostic testing. By analyzing clinical evidence, Charnot- Katsikas supports the development of policies that promote safe and effective patient care. This leadership role involves managing the review process for a wide range of molecular tests, ensuring that all assessments are based on the latest scientific research. Angella Charnot- Katsikas drives the clinical mission of the MolDX program by maintaining high standards for diagnostic accuracy and policy consistency. Through the application of specialized medical knowledge, Charnot- Katsikas ensures that the organization effectively manages the complexities of molecular diagnostic oversight.

Jacqueline Lekostaj, the Chief Medical Officer, Molecular Diagnostics at Palmetto GBA, directs the clinical strategy for the evaluation of molecular diagnostic services. Focusing on the integration of advanced genomic testing into federal health programs, Lekostaj ensures that all coverage decisions reflect current clinical standards. The Chief Medical Officer, Molecular Diagnostics works with internal teams to assess the impact of new diagnostic technologies on patient outcomes and program costs. By providing clinical oversight for the molecular diagnostics portfolio, Lekostaj maintains the integrity of the review process. This role involves engaging with the broader medical community to stay informed about advancements in diagnostic science. Jacqueline Lekostaj drives the development of policies that facilitate access to necessary diagnostic services while ensuring fiscal responsibility. Through the application of clinical expertise, Lekostaj supports the mission of the organization to provide high-quality, evidence-based oversight for molecular diagnostic testing within the federal healthcare system.